Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Times Interest Earned (2016 - 2025)

Guided Therapeutics' Times Interest Earned history spans 16 years, with the latest figure at -$3.86 for Q4 2025.

  • On a quarterly basis, Times Interest Earned rose 3.17% to -$3.86 in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.84, a 30.55% increase, with the full-year FY2025 number at -$3.84, up 30.52% from a year prior.
  • Times Interest Earned hit -$3.86 in Q4 2025 for Guided Therapeutics, down from -$3.76 in the prior quarter.
  • Over the last five years, Times Interest Earned for GTHP hit a ceiling of -$0.82 in Q3 2021 and a floor of -$21.81 in Q2 2023.
  • Historically, Times Interest Earned has averaged -$6.52 across 5 years, with a median of -$5.03 in 2025.
  • Biggest five-year swings in Times Interest Earned: crashed 863.18% in 2022 and later skyrocketed 59.96% in 2024.
  • Tracing GTHP's Times Interest Earned over 5 years: stood at -$4.35 in 2021, then plummeted by 211.33% to -$13.54 in 2022, then surged by 50.26% to -$6.74 in 2023, then skyrocketed by 40.84% to -$3.99 in 2024, then rose by 3.17% to -$3.86 in 2025.
  • Business Quant data shows Times Interest Earned for GTHP at -$3.86 in Q4 2025, -$3.76 in Q3 2025, and -$4.86 in Q2 2025.